Evaxion Biotech to Present Work on AI-Immunology Core Technology at Immuno UK 2021
COPENHAGEN, Denmark, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven
Source: finanznachrichten.de